Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2008343 | Peptides | 2006 | 5 Pages |
Abstract
The possibility for oral administration of peptide recombinant hirudin variant (rHV2-K47) as an anticoagulant agent was evaluated in several aspects. The proteolytic properties of rHV2-K47 and its stability during storage were examined by in vitro experiments. Radiolabeled rHV2-K47 was infused into the duodenum of rats and rHV2-K47 absorbed into serum was shown to be intact by electrophoresis pattern. The in vivo coagulation time of blood from mouse was prolonged significantly after oral administration of rHV2-K47. The bioavailability (F) of rHV2-K47 via oral route reached 10.11% in comparison with intravenous administration as gold standard. All the results suggested that rHV2-K47 could be delivered successfully via the oral route.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Xiaodong Cen, Jianquan Ni, Taochao Tan, Xia Liu, Changling Li, Jiepeng Chen, Yixiu Huang, Shenggeng Zhu, Qun Bi,